Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MSP Recovery, Inc. (MSPR) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, offering insight into its reimbursement recovery business, technology initiatives, capital structure, and listing status. MSP Recovery describes itself as a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, and its filings expand on how this model operates in practice.
Through annual reports on Form 10‑K and quarterly reports on Form 10‑Q, MSP Recovery provides detailed information on its portfolio of assigned healthcare claims, legal strategies under the Medicare Secondary Payer Act and other laws, technology platforms such as LifeWallet and LifeChain, and risk factors related to liquidity, litigation, and regulatory matters. These periodic reports also discuss non‑GAAP measures, impairment assessments of definite‑lived intangible assets, and management’s views on going‑concern considerations.
Current reports on Form 8‑K document material events affecting the company. Recent 8‑Ks describe strategic term sheets with investors such as Hazel Partners and Virage Capital Management, bridge funding and working‑capital facilities, debt‑to‑equity conversions, and amendments to agreements with YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement and related convertible promissory notes. Other 8‑Ks address reverse stock splits implemented to address Nasdaq’s minimum bid‑price rule, confidential settlements with insurers and pharmaceutical defendants, and the settlement of litigation with counterparties such as Cano Health.
Filings under Item 3.01 of Form 8‑K and related disclosures outline Nasdaq listing‑compliance issues, including deficiencies in minimum stockholders’ equity and bid‑price requirements, the company’s submission of a compliance plan, and the subsequent Nasdaq Hearings Panel decision to delist MSP Recovery’s common stock from the Nasdaq Capital Market. The company reports that it expects its common stock to trade on the OTC Markets OTCQB market under the ticker MSPR following suspension from Nasdaq, which is an important consideration for investors tracking trading venues.
Notifications of late filing on Form 12b‑25 (NT 10‑Q) provide context when MSP Recovery is unable to file a quarterly report by the prescribed deadline, such as delays related to a transition to a new independent registered public accounting firm. These notices explain the reasons for the delay and whether the company expects to file within the permitted extension period.
On this page, users can review MSP Recovery’s 10‑K and 10‑Q reports, 8‑K current reports, and other SEC submissions, while AI‑powered tools summarize key sections, highlight significant changes, and call out items such as liquidity discussions, debt and equity arrangements, reverse stock splits, and listing‑status disclosures. This helps readers quickly understand how MSP Recovery’s legal, technological, and financial developments are reflected in its official regulatory record.
MSP Recovery, Inc. amends its May 4, 2024 prospectus to register the resale of up to 32,220 shares of Class A Common Stock. The resale pool includes up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant); the exercise price is $0.4375 per share, meaning the company would receive only nominal proceeds if exercised. The supplement attaches a Form 8-K disclosing two one-time advances of $0.1 million each from Hazel Partners and VRM to support operations and accounts payable. The company completed a 1-for-7 reverse split effective September 1, 2025, and share figures in this supplement are adjusted for that split.
MSP Recovery, Inc. files a Prospectus Supplement updating its resale prospectus to register 56,896 shares of Class A Common Stock for resale by selling securityholders. The supplement incorporates an attached Form 8-K that discloses two one-time advances of $0.1 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operating needs and accounts payable. The filing notes the exercise price of certain warrants is $0.0175 per share and gives April 3, 2026 closing-market quotes; it also states a 1-for-7 reverse stock split became effective September 1, 2025. The advances are described as discrete accommodations and do not create ongoing funding commitments.
MSP Recovery, Inc. filed Prospectus Supplement No. 59 registering 285,715 shares of Class A common stock for potential resale or issuance to YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (the “Yorkville SEPA”). The supplement attaches a Form 8-K that discloses recent amendments to the Yorkville facility, multiple Convertible Notes advances and conversion terms, reductions to the SEPA Floor Price down to $0.50, a Nasdaq delisting and transition to OTCQB, and two one-time short-term advances of $0.1 million each from Hazel and VRM to support operations. The Yorkville SEPA provides up to $250 million of issuance capacity subject to an Ownership Limitation (9.99%) and previously an Exchange Cap that was lifted effective January 8, 2025. The company states it will not receive proceeds from Yorkville’s resale activity, though it may elect to sell shares to Yorkville under the SEPA.
MSP Recovery, Inc. files a Prospectus Supplement and attached Form 8-K describing a resale registration and short-term funding arrangements. The prospectus registers up to 909,982 shares of Class A common stock, up to 755,200,000 warrants, and up to 236,019 shares issuable upon warrant exercise. The supplement clarifies that Public Warrants have an adjusted exercise price of $0.4375 and New Warrants carry an exercise price of $50,312.50. The document also discloses two one-time advances: a $0.1 million discretionary advance from Hazel Partners Holdings, LLC to increase the Operational Collection Floor, and a $0.1 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC, each described as standalone accommodations with no commitment for further funding.
MSP Recovery, Inc. entered two small funding arrangements to access a total of $0.2 million of short-term cash. Through the Hazel Letter Agreement, its existing working capital lender Hazel Partners agreed, in its sole discretion, to a one-time $0.1 million advance under the Operational Collection Floor.
The company notes this advance is a standalone accommodation that does not reopen availability under the working capital credit facility and creates no commitment for future funding, and states it has no rights to, and no reasonable basis to expect, further advances from Hazel. Separately, VRM MSP Recovery Partners agreed to a one-time $0.1 million advance of recovery proceeds to support accounts payable, which must be reimbursed, along with certain prior consents, from any future financing, including potential debtor-in-possession financing if the company operates under Chapter 11 protection.
MSP Recovery, Inc. notified the SEC it cannot timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and submitted a Rule 12b-25 notification dated March 31, 2026. The company states it is experiencing severe liquidity constraints, is reliant on loan funding, and is evaluating financing and reorganization alternatives, including preparation for a potential restructuring process. The delay in filing is attributed to the company’s inability to fund the remaining external audit work with its independent auditors, Baker Tilly US, LLP, and the fact that the Chief Financial Officer resigned effective February 17, 2026, which the company says has created incremental operational constraints. The company is implementing interim measures for financial reporting and will file the Form 10-K when it can fund the remaining audit work and Baker Tilly completes its procedures.
MSP Recovery, Inc. registers the resale by selling securityholders of up to 32,220 shares of its Class A Common Stock, adjusted for a 1-for-7 reverse split. The registration includes up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant).
The prospectus supplement notes that should the CPIA Holder exercise the CPIA Warrant, the Company would only receive nominal proceeds because the exercise price is $0.4375 per share. The filing also attaches a Current Report describing two one-time advances totaling $0.2 million from Hazel and VRM to provide near-term liquidity; these advances are standalone accommodations and do not create ongoing funding commitments.
MSP Recovery, Inc. registers 285,715 shares of Class A Common Stock for resale by a selling securityholder under its prospectus supplement dated March 23, 2026. The shares were or may be issued to YA II PN, Ltd. ("Yorkville") pursuant to a Standby Equity Purchase Agreement (the "Yorkville SEPA").
The Yorkville SEPA contemplates up to $250 million of Class A Common Stock issuances subject to a 9.99% Ownership Limitation and an Exchange Cap that was effectively lifted January 8, 2025. Yorkville also provided convertible promissory notes with various conversion mechanics and a Floor Price floor that was reduced over time to a $0.50 Floor Price. The Company will not receive proceeds from Yorkville's resale of shares; proceeds from any direct sales to Yorkville under the SEPA would accrue to the Company.
MSP Recovery, Inc. files a prospectus supplement to register up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants to purchase Class A Common Stock, and up to 236,019 shares issuable upon exercise of warrants.
The supplement describes resale by selling securityholders of various share groups (Founder Shares, Private Units, Up-C exchangeable shares and other contract issuances) and discloses that cash proceeds to the company are expected to be nominal from the Public Warrants (less than $500) and that the company will not retain proceeds from the New Warrants. The filing also attaches a Form 8-K disclosing one-time advances: a $0.1 million discretionary Operational Collection Floor advance from Hazel Partners Holdings, LLC and a $0.1 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC; both advances are described as standalone, discretionary accommodations and do not create ongoing committed liquidity.
MSP Recovery, Inc. files a prospectus supplement registering 56,896 shares of Class A Common Stock for resale.
The supplement states the registered shares include 28,572 shares issuable upon exercise of VRM Warrants, 2,858 issued and 14,286 issuable to VRP, and 11,180 issued to Palantir. The VRM and VRP warrants have a $0.0175 exercise price, producing only nominal proceeds if exercised.
The filing also discloses two one-time advances: a $0.1 million advance from Hazel Partners (March 23, 2026) and a $0.1 million recovery-proceeds advance from VRM (March 20, 2026), each described as standalone accommodations with no commitment for further funding.